HomeCompareBRNHF vs EPRT

BRNHF vs EPRT: Dividend Comparison 2026

BRNHF yields 2500.00% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BRNHF wins by $80609755877.30M in total portfolio value
10 years
BRNHF
BRNHF
● Live price
2500.00%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80609755877.37M
Annual income
$74,729,580,081,858,750.00
Full BRNHF calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — BRNHF vs EPRT

📍 BRNHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBRNHFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BRNHF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BRNHF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BRNHF
Annual income on $10K today (after 15% tax)
$212,500.00/yr
After 10yr DRIP, annual income (after tax)
$63,520,143,069,579,940.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, BRNHF beats the other by $63,520,143,069,568,744.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BRNHF + EPRT for your $10,000?

BRNHF: 50%EPRT: 50%
100% EPRT50/50100% BRNHF
Portfolio after 10yr
$40304877938.72M
Annual income
$37,364,790,040,935,960.00/yr
Blended yield
92.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

BRNHF
No analyst data
Altman Z
1.0
Piotroski
3/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BRNHF buys
0
EPRT buys
0
No recent congressional trades found for BRNHF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBRNHFEPRT
Forward yield2500.00%3.97%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$80609755877.37M$64.3K
Annual income after 10y$74,729,580,081,858,750.00$13,170.85
Total dividends collected$80198875900.38M$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BRNHF vs EPRT ($10,000, DRIP)

YearBRNHF PortfolioBRNHF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$260,700$250,000.00$11,212$512.01+$249.5KBRNHF
2$6,370,070$6,091,121.50$12,689$692.09+$6.36MBRNHF
3$145,912,632$139,096,656.81$14,521$944.30+$145.90MBRNHF
4$3,133,830,814$2,977,704,297.75$16,841$1,302.88+$3133.81MBRNHF
5$63,122,812,060$59,769,613,088.96$19,841$1,821.64+$63122.79MBRNHF
6$1,192,683,724,131$1,125,142,315,226.76$23,818$2,587.47+$1192683.70MBRNHF
7$21,144,559,711,004$19,868,388,126,183.19$29,230$3,744.65+$21144559.68MBRNHF
8$351,818,906,448,043$329,194,227,557,269.44$36,816$5,540.38+$351818906.41MBRNHF
9$5,495,491,397,671,320$5,119,045,167,771,913.00$47,806$8,413.17+$5495491397.62MBRNHF
10$80,609,755,877,367,070$74,729,580,081,858,750.00$64,324$13,170.85+$80609755877.30MBRNHF

BRNHF vs EPRT: Complete Analysis 2026

BRNHFStock

Broncus Holding Corporation, a medical device company, focuses on the development of interventional pulmonology products in Mainland China, the European Union, the United States, and internationally. The company provides navigation products, such as LungPoint Virtual Bronchoscopic Navigation, a computer-assisted image-based navigation software system; LungPoint Plus, a system that provides real-time navigation within the airways for lung biopsy and other procedures; and LungPro, a virtual bronchoscopic navigation product that provides three-dimensional real-time guided transbronchial needle aspiration and proprietary parenchymal navigation. It also offers treatment products comprising InterVapor, a targeted bronchoscopic thermal vapor ablation to ablate the diseased hyper-inflated lung segments; RF Generator + RF Ablation Catheter, a radiofrequency ablation system used in conjunction with a disposable lung radiofrequency ablation catheter, as well as radiofrequency ablation system that targets lung cancer; and H-Marker, a pulmonary surgical marker. In addition, the company provides treatment products, such as BioStarNeedle, a single use ultrasound-guided aspiration needle for retrieval of tissue samples; FleXNeedle, a multipurpose biopsy needle; Archimedes Sheath, a sterile single-use flexible tube that provides a working channel during a bronchoscopic procedure; Archimedes Dilation Balloon, a sterile single-use flexible tube with a balloon at or near the distal tip that is inserted through the bronchoscope or sheath and used to dilate the target lung tissue of the bronchial tree; and Steerable Sheath, a steerable sheath adjustment handle and a working channel. Broncus Holding Corporation was incorporated in 2012 and is headquartered in Hangzhou, China.

Full BRNHF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this BRNHF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BRNHF vs SCHDBRNHF vs JEPIBRNHF vs OBRNHF vs KOBRNHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.